These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 15146294

  • 1. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [Abstract] [Full Text] [Related]

  • 2. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L.
    Cancer Res; 2002 Mar 15; 62(6):1884-9. PubMed ID: 11912169
    [Abstract] [Full Text] [Related]

  • 3. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.
    Tagliani E, Guermonprez P, Sepúlveda J, López-Bravo M, Ardavín C, Amigorena S, Benvenuti F, Burrone OR.
    J Immunol; 2008 Mar 01; 180(5):3201-9. PubMed ID: 18292544
    [Abstract] [Full Text] [Related]

  • 4. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H, Okamoto T, Kanzaki M, Inozume T, Shibagaki N, Shimada S.
    Br J Dermatol; 2010 Jan 01; 162(1):29-41. PubMed ID: 19863514
    [Abstract] [Full Text] [Related]

  • 5. Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses.
    Herr W, Ranieri E, Olson W, Zarour H, Gesualdo L, Storkus WJ.
    Blood; 2000 Sep 01; 96(5):1857-64. PubMed ID: 10961887
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 01; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 7. CD4-8- dendritic cells prime CD4+ T regulatory 1 cells to suppress antitumor immunity.
    Zhang X, Huang H, Yuan J, Sun D, Hou WS, Gordon J, Xiang J.
    J Immunol; 2005 Sep 01; 175(5):2931-7. PubMed ID: 16116179
    [Abstract] [Full Text] [Related]

  • 8. Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity.
    Mitsui H, Inozume T, Kitamura R, Shibagaki N, Shimada S.
    J Invest Dermatol; 2006 Aug 01; 126(8):1804-12. PubMed ID: 16645583
    [Abstract] [Full Text] [Related]

  • 9. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
    Duewell P, Kisser U, Heckelsmiller K, Hoves S, Stoitzner P, Koernig S, Morelli AB, Clausen BE, Dauer M, Eigler A, Anz D, Bourquin C, Maraskovsky E, Endres S, Schnurr M.
    J Immunol; 2011 Jul 01; 187(1):55-63. PubMed ID: 21613613
    [Abstract] [Full Text] [Related]

  • 10. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
    De Smedt T, Smith J, Baum P, Fanslow W, Butz E, Maliszewski C.
    J Immunol; 2002 Jan 15; 168(2):661-70. PubMed ID: 11777959
    [Abstract] [Full Text] [Related]

  • 11. CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.
    Umeshappa CS, Huang H, Xie Y, Wei Y, Mulligan SJ, Deng Y, Xiang J.
    J Immunol; 2009 Jan 01; 182(1):193-206. PubMed ID: 19109150
    [Abstract] [Full Text] [Related]

  • 12. Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L.
    Buonocore S, Haddou NO, Moore F, Florquin S, Paulart F, Heirman C, Thielemans K, Goldman M, Flamand V.
    J Leukoc Biol; 2008 Sep 01; 84(3):713-20. PubMed ID: 18567840
    [Abstract] [Full Text] [Related]

  • 13. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S, Yuan J, Xiang J.
    J Leukoc Biol; 2007 Oct 01; 82(4):829-38. PubMed ID: 17626150
    [Abstract] [Full Text] [Related]

  • 14. Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells.
    Kato M, Nakamura Y, Suda T, Ozawa Y, Inui N, Seo N, Nagata T, Koide Y, Kalinski P, Nakamura H, Chida K.
    Cancer Immunol Immunother; 2011 Jul 01; 60(7):1029-38. PubMed ID: 21519830
    [Abstract] [Full Text] [Related]

  • 15. Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
    Lorenzi S, Mattei F, Sistigu A, Bracci L, Spadaro F, Sanchez M, Spada M, Belardelli F, Gabriele L, Schiavoni G.
    J Immunol; 2011 May 01; 186(9):5142-50. PubMed ID: 21441457
    [Abstract] [Full Text] [Related]

  • 16. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
    Lemos MP, Fan L, Lo D, Laufer TM.
    J Immunol; 2003 Nov 15; 171(10):5077-84. PubMed ID: 14607905
    [Abstract] [Full Text] [Related]

  • 17. Differential capacity of CD8+ alpha or CD8- alpha dendritic cell subsets to prime for eosinophilic airway inflammation in the T-helper type 2-prone milieu of the lung.
    Hammad H, de Vries VC, Maldonado-Lopez R, Moser M, Maliszewski C, Hoogsteden HC, Lambrecht BN.
    Clin Exp Allergy; 2004 Dec 15; 34(12):1834-40. PubMed ID: 15663556
    [Abstract] [Full Text] [Related]

  • 18. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y, Zhang H, Li W, Deng Y, Munegowda MA, Chibbar R, Qureshi M, Xiang J.
    J Immunol; 2010 Nov 01; 185(9):5268-78. PubMed ID: 20881190
    [Abstract] [Full Text] [Related]

  • 19. A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.
    Chiang CL, Kandalaft LE, Tanyi J, Hagemann AR, Motz GT, Svoronos N, Montone K, Mantia-Smaldone GM, Smith L, Nisenbaum HL, Levine BL, Kalos M, Czerniecki BJ, Torigian DA, Powell DJ, Mick R, Coukos G.
    Clin Cancer Res; 2013 Sep 01; 19(17):4801-15. PubMed ID: 23838316
    [Abstract] [Full Text] [Related]

  • 20. Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant.
    Wan T, Zhou X, Chen G, An H, Chen T, Zhang W, Liu S, Jiang Y, Yang F, Wu Y, Cao X.
    Blood; 2004 Mar 01; 103(5):1747-54. PubMed ID: 14592822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.